WCAS: Investing in Better Healthcare

13

KINICITI , a platform built to support innovation and development of cell and gene therapies, can replicate actual human cells through induced pluripotent stem cells, allowing researchers to assess performance against relevant human biology before conducting clinical trials

5 Drive innovation Innovation is critical to improving quality and creating

differentiation in healthcare. While all portfolio companies are continually innovating to enhance their value proposition and differentiate themselves, some companies are innovating at the leading edge of life sciences. Current portfolio examples include cell and gene therapies, manufacturing services for biologics, and antibody drug conjugates. As another example, we also incorporate value-based care (VBC) models into investment and business strategies to achieve better outcomes. These models align provider incentives with health outcomes by paying for quality of care rather than the quantity of services rendered.

Made with FlippingBook Digital Proposal Creator